BOCA RATON, Fla. (PRWEB) August 14, 2018
Lexington Int’l enters a new category in their laser device range with the introduction of its first cap device, the Laser 272 featuring BioLight Comfort Design, marketed under the name RegrowMD by HairMax (MD stands for Medical Device). This new addition to the HairMax® family expands the company’s laser portfolio, providing the widest array of treatment experiences.
In June of 2018, the RegrowMD by HairMax Laser 272 was granted FDA 510(k) Clearance for the treatment of Androgenetic Alopecia in both men and women: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K180885 This brings the total number of FDA Clearances the company has been granted to eight, which required the submission of not only safety, but also effectiveness data based on scientifically designed clinical research studies.
Lexington Int’l. innovated the first breakthrough home-use laser hair growth device to be cleared by the FDA in 2007. The company’s commitment to scientific research and studies is unprecedented in the industry. Lexington has conducted more clinical trials than any other company and continues to set the highest standards. Seventeen years later, 1.5+ million HairMax devices have been sold in over 170 countries and the company remains the worldwide market leader.
Recently, Lexington International has been declared MDSAP (Medical Device Single Audit Program) compliant. This certification is the most recognized quality system assessment standard for the medical device industry.
Lexington Innovates Again - RegrowMD Laser 272 is the cap that’s designed for better results. Our unique BioLight Comfort feature incorporates 272 laser diodes within a flexible, lightweight inner liner. Each laser diode delivers nourishing laser light through openings which provide a direct flow of light energy to reach your hair & scalp for optimal results.
A laser for every lifestyle – Lexington has clinically proven that laser therapy is effective to treat hair loss and stimulate hair growth in both men and women suffering from androgenetic alopecia, with the best results achieved with regular and consistent usage. That’s why Lexington offers the widest range of laser devices for every lifestyle. From the patented hair parting teeth mechanism that parts the hair for optimal laser light delivery to the scalp found in the LaserCombs (targeted treatment) and LaserBands (fastest treatment, as little as 90 seconds), to the new RegrowMD Laser 272 cap - HairMax gives their customers the treatment experience they want.
Better design, affordably priced - Lexington is committed to making state of the art laser hair growth devices available to as many people at the best prices their high standards allow. The RegrowMD Laser 272 is offered at $1499, at half the price of other cap devices.
HairMax Cares - David Michaels, Founder of Lexington Int’l, states: “As market leader, we feel a special responsibility to support men and women in treating their hair loss in the way that best fits their needs, lifestyle and budget, making this once exclusive therapy available to everyone. With the addition of the Laser 272, we now offer, by far, the widest selection of FDA Cleared hair growth devices on the market. It is important to the company that we do offer a cap style device at a fair price.”
The Laser 272 is now available on the RegrowMD website: http://www.regrowmd.com. The website has a clean design with functionality that allows visitors to easily access the information they want with a quick, secure checkout process. In addition, it is offered on http://www.HairMax.com, joining the HairMax family of laser devices.
Lexington’s laser hair growth devices are sold in physician offices, through home-shopping channels and via ecommerce, and continue to consistently set industry standards in the expanding laser device market.
About Lexington International, LLC
Based in Boca Raton, Lexington Int’l is the global leader in laser hair growth technology. Lexington laser devices are the first device on the market to receive FDA Clearance as a medical device to treat hair loss and stimulate hair growth. Lexington laser devices have been the subject of 7 clinical studies proving both efficacy and safety with an over 90% success rate. Today, Lexington laser devices hold 8 FDA clearances and 14 medical device licenses world-wide. Sold in over 170 countries, Lexington has helped over 1.5+ million men and women treat their hair loss and enrich their lives.
For more information, please visit: http://www.regrowmd.com
Francesca Dubsky, Director of Marketing
Lexington International, LLC
5614170200 ext 124